Confluence Discovery Technologies Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
34
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$24.3M
Confluence Discovery Technologies General Information
Description
Developer of kinase inhibitors intended to treat cancer and inflammatory disease. The company's inhibitors target key enzymes involved in the regulation of cancer growth, survival, and metastasis or in the reduction of chronic inflammation, enabling healthcare providers to treat cancer and autoimmune or inflammatory diseases.
Contact Information
Website
www.confluencediscovery.com(Operating Subsidiary)
Corporate Office
- 4340 Duncan Avenue
- Suite 400
- Saint Louis, MO 63110
- United States
Corporate Office
- 4340 Duncan Avenue
- Suite 400
- Saint Louis, MO 63110
- United States
Confluence Discovery Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 03-Aug-2017 | $24.3M | Completed | Generating Revenue | ||
| 10. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series A1) | 06-Apr-2016 | Completed | Product Development | |||
| 8. Grant | 01-Jan-2016 | Completed | Product Development | |||
| 7. Early Stage VC | 23-Jul-2015 | Completed | Product Development | |||
| 6. Early Stage VC (Series A) | 04-Feb-2014 | Completed | Product Development | |||
| 5. Grant | 01-Jan-2014 | Completed | Product Development | |||
| 4. Early Stage VC | 24-Oct-2013 | Completed | Startup | |||
| 3. Grant | 02-May-2013 | $289K | $4.2M | Completed | Startup | |
| 2. Early Stage VC (Series A) | 17-Sep-2012 | $4.2M | $4.2M | Completed | Startup |
Confluence Discovery Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Prime | ||||||||
| Series A |
Confluence Discovery Technologies Comparisons
Industry
Financing
Details
Confluence Discovery Technologies Competitors (12)
One of Confluence Discovery Technologies’s 12 competitors is Phaxiam, a Formerly VC-backed company based in Lyon, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Phaxiam | Formerly VC-backed | Lyon, France | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| CTI BioPharma | Formerly VC-backed | Seattle, WA | ||||
| Aura Biosciences | Formerly VC-backed | Boston, MA | ||||
| Amgen | Formerly PE-Backed | Thousand Oaks, CA |
Confluence Discovery Technologies Patents
Confluence Discovery Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240002380-A1 | Rev-erb agonists | Inactive | 16-Oct-2020 | ||
| FR-3110963-A1 | The industrial continuous food cooker | Inactive | 28-May-2020 | ||
| FR-2475108-A1 | Elastically mounted roller blind - has twisted elastic tie providing small and constant recall force for blind curtain | Inactive | 04-Feb-1980 | E06B9/60 |
Confluence Discovery Technologies Signals
Confluence Discovery Technologies Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accelerate St. Louis | Accelerator/Incubator | Minority | ||
| BioGenerator Ventures | Venture Capital | Minority | ||
| DFJ Mercury | Venture Capital | Minority | ||
| Epidarex Capital | Venture Capital | Minority | ||
| Helix Funds | Real Estate | Minority |
Confluence Discovery Technologies FAQs
-
When was Confluence Discovery Technologies founded?
Confluence Discovery Technologies was founded in 2010.
-
Where is Confluence Discovery Technologies headquartered?
Confluence Discovery Technologies is headquartered in Saint Louis, MO.
-
What is the size of Confluence Discovery Technologies?
Confluence Discovery Technologies has 34 total employees.
-
What industry is Confluence Discovery Technologies in?
Confluence Discovery Technologies’s primary industry is Drug Discovery.
-
Is Confluence Discovery Technologies a private or public company?
Confluence Discovery Technologies is a Private company.
-
What is the current valuation of Confluence Discovery Technologies?
The current valuation of Confluence Discovery Technologies is .
-
What is Confluence Discovery Technologies’s current revenue?
The current revenue for Confluence Discovery Technologies is .
-
How much funding has Confluence Discovery Technologies raised over time?
Confluence Discovery Technologies has raised $10M.
-
Who are Confluence Discovery Technologies’s investors?
Accelerate St. Louis, BioGenerator Ventures, DFJ Mercury, Epidarex Capital, and Helix Funds are 5 of 10 investors who have invested in Confluence Discovery Technologies.
-
Who are Confluence Discovery Technologies’s competitors?
Phaxiam, Kite Pharma, CTI BioPharma, Aura Biosciences, and Amgen are some of the 12 competitors of Confluence Discovery Technologies.
-
When was Confluence Discovery Technologies acquired?
Confluence Discovery Technologies was acquired on 03-Aug-2017.
-
Who acquired Confluence Discovery Technologies?
Confluence Discovery Technologies was acquired by Aclaris Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process